Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Concert makes regulatory and clinical leadership appointments

This article was originally published in SRA

Executive Summary

Concert Pharmaceuticals, a US-based clinical-stage biotechnology company, has named Mark Roessel vice president of regulatory affairs and quality assurance and LuAnn Sabounjian vice president of clinical operations. Mr Roessel was previously vice president of regulatory affairs at Indevus Pharmaceuticals, which was acquired by Endo Pharmaceuticals. Ms Sabounjian also joins from Indevus, where she held several clinical roles of increasing responsibility over 20 years; most recently she was vice president of clinical development.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS116121

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel